StockData
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd (TLX) stock

TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.96+0.11 (+1.19%)

Close on Nov 18, 2026Market cap $3.04BP/E –Yield –

Telix Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Telix Pharmaceuticals's pe ratio was 74.3× on Feb 27, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Feb 27, 202674.3×−2.5
2025Dec 31, 202576.7×–

More Telix Pharmaceuticals figures

See a number that looks wrong?